Article

Sydney Morning HeraldSydney Morning Herald on 2021-10-25 15:15

From the heart: Pandemic no barrier for medtech’s ASX listing

AI-driven heart disease fighter Artrya hopes to hit the ASX boards as blue-chip investors pile into medtech stocks.

Related news